Abstract
Recently, COVID-19 caused mainly by the fast-spreading as compared with primary infections of new variant 'Omicron-SARS-CoV-2, the blind-spots, may have killed nearly 3 million only in India, and the whole world, opening a new chapter that has impacted our lives, and the highest number of Covid-19 deaths due to lack of vaccines gasping for air now. So, it is urgently needed the ‘Universal-Preventive-Emergency-Vaccine for All’ to tackle the awkward situation. Primarily, it has been already observed that the Ginger-MT-biomedicines, prepared from the rhizome of ginger (Zingiber officinale Rosc.), at an extremely-ultra-low-doses, highly effective against coronavirus controlling-COVID-19, and other diseases by increasing natural immunity. Now the aims and objective of the present ‘Notable-Case-Reports (NCR)’ are to see, record, and confirm the efficacy of the ‘High-Diluted-Traditional-Ginger-MT-Biomedicines (HDTGMTBM)’, against naturally occurring coronavirus infections or re-infections of the different-COVID-19-areas of the Burdwan-Municipality, Purba Bardhaman, West Bengal, India. And to highlight novel and significant future aspects of the study with the ‘Black Ginger’, the rhizome of Kaempferia parviflora. As a result in the ‘New-Year-2022; “‘Traditional-And-Black-Ginger-Biomedicines (TABGBM)’ May Be Act As ‘Notable-Universal-Preventive-Emergenc Vaccine (NUPEV)’ Against 'Future-A to Z-Diseases (FAZD)’ Enriched ‘Clinical-Case-Reports-Medical-Science-Technology-Communication-Research-Innovation-Global-Health-Ecology-Application (CCRMSTCRIGHEA)”. And in near future, both the Ginger MT-Biomedicines may easily tackle many diseases and complications. I will be ‘NUPEV’ due to medicines formulations, very-low-toxicity, potential efficacy, and different phytochemicals, eco-friendly-side-effects-free, cost-effective, easily prepare-able, easily available, easily-manufacture-able, easily-equitable, easily-marketable and easily-supply-able, etc. And in the future, it will be ‘Policy Initiative Potentially Life-Saving 'Future-A to Z-Vaccine for All’.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
